The primary one is competition from other GLP-1 drugs, especially from Eli Lillys Mounjaro (tirzepatide), which has shown greater efficacy in weight loss and diabetes control
Collectively, this human gut microbiota phenotype-directed approach offers potential for developing precision medicine and provides insights into translational research
If youre interested in learning more about the wide variety of services we offer, please reach out to us!
Exendin-4 protects Abeta(1-42) oligomer-induced PC12 cell apoptosis
Exogenous glucose-dependent insulinotropic polypeptide worsens post prandial hyperglycemia in type 2 diabetes
Because it's, it's different for every provider, but what I'm seeing a lot of providers doing, myself included, is using just the starting dose of these GLP ones and staying there